Kinetics Medical Adv C (KRXCX)
* As of 31-Mar-14
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for KRXCX at this time.
|Symbol||% Assets||YTD Return %|
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||2.14%|
Performance & Risk
|5y Avg Return:||18.50%|
|Rank in Category (ytd):||88|
|% Rank in Category (ytd):||67.18%|
|Morningstar Risk Rating:||4|
The investment seeks long-term growth of capital.
The fund normally invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, generally, with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified. View More